Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Qingdao Haier Biomedical Co., Ltd.
  6. News
  7. Summary
    688139   CNE100003P25

QINGDAO HAIER BIOMEDICAL CO., LTD.

(688139)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-09-25
57.65 CNY   -0.10%
08/25Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
07/14Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions
AQ
07/13Suzhou Basecare Signs Strategic Collaboration Framework Deal with Qingdao Haier Biomedical
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on February 7, 2022.

07/01/2022 EDT

From April 1, 2022 to June 30, 2022, the company has repurchased 79,620 shares, representing 0.03% for CNY 4.86 million. With this, the company has completed the repurchase of 759,620 shares, representing 0.24% for CNY 54.71 million under the buyback announced on February 7, 2022.


© S&P Capital IQ 2022
All news about QINGDAO HAIER BIOMEDICAL CO., LTD.
08/25Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended Jun..
CI
07/14Basecare Medical and Haier Biomedical Join Forces to Build Cryopreservation Solutions
AQ
07/13Suzhou Basecare Signs Strategic Collaboration Framework Deal with Qingdao Haier Biomedi..
MT
07/01Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on..
CI
04/28Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended..
CI
04/02Tranche Update on Qingdao Haier Biomedical Co., Ltd.'s Equity Buyback Plan announced on..
CI
02/16Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended Dec..
CI
02/06Qingdao Haier Biomedical Co., Ltd. announces an Equity Buyback for CNY 100 million wort..
CI
02/06Qingdao Haier Biomedical Co., Ltd. authorizes a Buyback Plan.
CI
2021Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months Ended S..
CI
More news
Financials
Sales 2022 2 872 M 402 M 402 M
Net income 2022 615 M 86,1 M 86,1 M
Net Debt 2022 - - -
P/E ratio 2022 29,7x
Yield 2022 -
Capitalization 18 235 M 2 554 M 2 554 M
Capi. / Sales 2022 6,35x
Capi. / Sales 2023 4,79x
Nbr of Employees 2 400
Free-Float 33,7%
Chart QINGDAO HAIER BIOMEDICAL CO., LTD.
Duration : Period :
Qingdao Haier Biomedical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QINGDAO HAIER BIOMEDICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 57,65 CNY
Average target price 126,00 CNY
Spread / Average Target 119%
EPS Revisions
Managers and Directors
Zhan Jie Liu General Manager & Director
Rui Juan Mo Chief Financial Officer
Li Xia Tan Chairman
Xue Juan Zhang Chairman-Supervisory Board
Jiang Tao Zhang Chief Engineer
Sector and Competitors